Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Peptic Ulcer

Free Subscription Articles published in Aliment Pharmacol Ther Retrieve available abstracts of 103 articles: HTML format Text format

Single Articles

March 2010
1. JOHNSTONE J , Nerenberg K, Loeb M
   Meta-analysis: proton pump inhibitor use and risk of community acquired pneumonia.
   Aliment Pharmacol Ther. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
2. MARTIN-MERINO E , Ruigomez A, Garcia Rodriguez LA, Wallander MA, et al
   Depression and treatment with antidepressants are associated with the development of gastroesophageal reflux disease.
   Aliment Pharmacol Ther. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. LEE RD , Mulford D, Wu J, Atkinson SN, et al
   The effect of time-of-day dosing on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR - evidence for dosing flexibility with a Dual Delayed Release proton pump inhibitor.
   Aliment Pharmacol Ther. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. MOLINA-INFANTE J , Perez-Gallardo B, Fernandez-Bermejo M, Hernandez-Alonso M, et al
   Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.
   Aliment Pharmacol Ther. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. MINER JR PB , McKean LA, Gibb RD, Erasala GN, et al
   Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
   Aliment Pharmacol Ther. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. FASS R , Delemos B, Nazareno L, Kao R, et al
   Clinical trial: maintenance intermittent therapy with rabeprazole 20 mg in patients with symptomatic gastro-oesophageal reflux disease - a double-blind, placebo-controlled, randomized study.
   Aliment Pharmacol Ther. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. MINER P , Delemos B, Xiang J, Lococo J, et al
   Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-hour intragastric acidity and oesophageal acid exposure: a randomised, study in gastroesophageal reflux disease (GERD) patients with a history of nocturnal heartburn.
   Aliment Pharmacol Ther. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. HIRAISHI H , Haruma K, Miwa H, Goto H, et al
   Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection - the results of a multicentre, double-blind, randomised clinical trial (IMPACT study).
   Aliment Pharmacol Ther. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
9. KWOK CS , Loke YK
   Meta-analysis: effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel.
   Aliment Pharmacol Ther. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. JOHNSON T , Gerson L, Hershcovici T, Stave C, et al
    Systematic review: the effect of carbonated beverages on gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
11. TURCO R , Martinelli M, Miele E, Roscetto E, et al
    Proton pump inhibitors as a risk factor for pediatric Clostridium difficile infection.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. HUNT RH , Armstrong D, Yaghoobi M, James C, et al
    Clinical trials: Pharmacodynamics and pharmacokinetics of S-tenatoprazole-Na 30 mg, 60 mg and 90 mg versus esomeprazole 40 mg in healthy male subjects.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
13. WO JM , Eversmann J, Mann S
    Pharmacokinetic profile of immediate-release omeprazole in patients with gastroesophageal reflux associated with gastroparesis.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. VAIRA D , Vakil N, Gatta L, Ricci C, et al
    Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive dyspeptic patients.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
15. CHAN Y , Ching JY, Cheung CM, Tsoi KK, et al
    Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease (GORD): the GORD-QOL questionnaire.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
16. HUNFELD NG , Touw DJ, Mathot RA, Mulder PG, et al
    A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. DE GROOT NL , Burgerhart JS, van de Meeberg PC, de Vries DR, et al
    Systematic review: effect of conservative and surgical treatment for obesity on gastroesophageal reflux disease.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. JONES R , Junghard O, Dent J, Vakil N, et al
    Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. PEURA DA , Metz DC, Dabholkar AH, Paris MM, et al
    Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
20. CAI S , Garcia Rodriguez LA, Masso-Gonzalez EL, Hernandez-Diaz S, et al
    Uncomplicated peptic ulcer in the UK: trends from 1997 - 2005.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. NICHITA C , Abdou AE, Maerten P, Herranz M, et al
    A single dose of intravenous esomeprazole decreases gastric secretion in healthy volunteers.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. ORR WC
    Review article: sleep related gastroesophageal reflux as a distinct clinical entity.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. HUNGIN AP , Hill C, Raghunath A
    Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia.
    Aliment Pharmacol Ther. 2009;30:331-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. HOWDEN CW , Larsen LM, Perez MC, Palmer R, et al
    Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive esophagitis - maintenance of healing and symptom relief.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. TAN VP , Wong BC
    A false sense of security; symptom control does not predict healing of oesophagitis on proton pump inhibitors.
    Aliment Pharmacol Ther. 2009;30:307-8.
    PubMed     Text format     Related articles   
    
    
    July 2009
26. GISBERT JP , Calvet X
    Review article: Helicobacter pylori-negative duodenal ulcer disease.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. TANEIKE I , Nami A, O'Connor A, Fitzgerald N, et al
    The analysis of drug resistance and virulence-factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status?
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. REIMER C , Bytzer P
    Long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. MUSUMBA C , Pritchard DM, Pirmohamed M
    Review article: Cellular and molecular mechanisms of NSAID-induced peptic ulceration.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. DRIES AM , Richardson P, Cavazo J, Abraham NS, et al
    Therapeutic intent of proton pump inhibitor prescription among elderly NSAID users.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. DESAI JC , Goo T, Fukata M, Sanyal S, et al
    NSAID-induced antral ulcers are associated with distinct changes in mucosal gene expression.
    Aliment Pharmacol Ther. 2009;30:71-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
32. EDWARDS SJ , Lind T, Lundell L, DAS R, et al
    Systematic review: standard- and double-dose proton pump inhibitors (PPIs) for the healing of severe erosive oesophagitis - a mixed treatment comparison of randomised controlled trials.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. PEURA DA , Riff DS, Snoddy AM, Fennerty MB, et al
    Clinical trial: Lansoprazole 15 or 30 mg once daily vs placebo for treatment of frequent nighttime heartburn in self-treating subjects.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. FRAZZONI M , Savarino E, Manno M, Melotti G, et al
    A study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. SADIC J , Borgstrom A, Manjer J, Toth E, et al
    Bleeding peptic ulcer - time trends in incidence, treatment and mortality in Sweden.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. LABENZ J , Armstrong D, Zetterstrand S, Eklund S, et al
    Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis--results from the maintenance phase of the EXPO study.
    Aliment Pharmacol Ther. 2009;29:1165-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
37. TSENG GY , Fang CT, Lin HJ, Yang HB, et al
    Efficacy of intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uremia: a case-control study.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. FURUTA T , Kodaira C, Nishino M, Yamade M, et al
    [(13)C]-pantoprazole breath test to predict CYP2C19 phenotype and efficacy of a proton pump inhibitor, lansoprazole.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. YUAN YH , Wang C, Yuan Y, H Hunt R, et al
    Meta-analysis: Incidence of endoscopic gastric and duodenal ulcers in placebo arms of randomized placebo-controlled NSAIDs trials.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. MURUGESAN SV , Varro A, Pritchard DM
    Review article: Strategies to determine whether hypergastrinaemia is due to Zollinger-Ellison syndrome rather than a more common benign cause.
    Aliment Pharmacol Ther. 2009;29:1055-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. LABENZ J , Armstrong D, Zetterstrand S, Eklund S, et al
    Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis--results from the EXPO study.
    Aliment Pharmacol Ther. 2009;29:959-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
42. SPECHLER SJ , Barker PN, Silberg DG
    Intragastric acid control in patients who have Barrett's esophagus: comparison of once- and twice-daily regimens of esomeprazole and lansoprazole.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. LEE ES , Kim N, Lee SH, Park YS, et al
    Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive esophagitis and non-erosive reflux disease.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. FASS R , Chey WD, Zakko SF, Andhivarothai N, et al
    Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with nonerosive reflux disease.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
45. FRESTON JW , Hisada M, Peura DA, Haber MM, et al
    The clinical safety of long-term lansoprazole for the maintenance of healed erosive esophagitis.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. ETMINAN M , Levesque L, Fitzgerald JM, Brophy JM, et al
    Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
47. METZ DC , Vakily M, Dixit T, Mulford D, et al
    Dual Delayed Release Formulation of Dexlansoprazole MR, A Novel Approach to Overcome the Limitations of Conventional Single Release Proton Pump Inhibitor Therapy.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. LEE RD , Vakily M, Mulford D, Wu J, et al
    The Effect and Timing of Food on the Pharmacokinetics and Pharmacodynamics of Dexlansoprazole MR, a Novel Dual Delayed Release Formulation of a Proton Pump Inhibitor: Evidence for Dosing Flexibility.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. NAM SY , Choi IJ, Nam BH, Park KW, et al
    Obesity and weight gain as risk factors for erosive esophagitis in men.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. SUNG JJ , Kuipers EJ, El-Serag HB
    Systematic review: update on the global incidence and prevalence of peptic ulcer disease.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. METZ DC , Howden CW, Perez MC, Larsen L, et al
    Clinical Trial: Dexlansoprazole MR, a proton pump inhibitor with Dual Delayed Release technology, effectively controls symptoms and prevents relapse in patients with healed erosive esophagitis.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. EGGLESTON A , Katelaris PH, Nandurkar S, Thorpe P, et al
    Clinical trial: The treatment of gastro-oesophageal reflux disease in primary care - prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. TOLIA V , Vandenplas Y
    Systematic review: the extra-oesophageal symptoms of gastro-oesophageal reflux disease in children.
    Aliment Pharmacol Ther. 2009;29:258-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
54. SKINNER BJ , Gray JR, Attara GP
    Increased health costs from mandated Therapeutic Substitution of proton pump inhibitors in British Columbia.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. GOH KL , Wong HT, Lim CH, Rosaida MS, et al
    Time trends in peptic ulcer, erosive reflux esophagitis, gastric and esophageal cancers in a multiracial asian population.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. SHARMA P , Shaheen NJ, Perez MC, Pilmer BL, et al
    Healing of erosive oesophagitis with TAK-390MR, a proton pump inhibitor with a novel dual delayed-release formulation - results from two randomized controlled studies.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
57. NOCON M , Labenz J, Jaspersen D, Leodolter A, et al
    Health-related quality of life in patients with gastroesophageal reflux disease under routine care - 5-years follow-up results of the proGERD study.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. HOLTMANN G , Chassany O, Devault KR, Schmitt H, et al
    International validation of a health related quality of life (HRQoL) questionnaire in patients with erosive gastroesophageal reflux disease (GERD).
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. DALTON BR , Lye-Maccannell T, Henderson EA, Maccannel DR, et al
    Proton Pump Inhibitors (PPI) significantly increase the risk of Clostridium difficile infection in a Low Endemicity, Non-outbreak Hospital Setting: optimizing risk and benefit of PPI therapy.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
60. VAN RENSBURG C , Barkun AN, Racz I, Fedorak R, et al
    Intravenous pantoprazole versus ranitidine for the prevention of PEPTIC ulcer rebleeding: a multicenter, multinational, randomized trial.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. VAN BOXEL OS , Hagenaars MP, Smout AJ, Siersema PD, et al
    Sociodemographic factors influence chronic proton pump inhibitor use in a large population in the Netherlands.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. EL-SERAG H , Hill C, Jones R
    Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care - a review of studies using the UK General Practice Research Database.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. RAGHUNATH AS , Hungin AP, Mason J, Jackson W, et al
    Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. MIZYED I , Fass SS, Fass R
    Gastroesophageal reflux disease and psychological comorbidity.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
65. VAN VLIET EP , Steyerberg EW, Otten HJ, Rudolphus A, et al
    The effect of guideline implementation for proton pump inhibitor (PPI) prescription on two pulmonary medicine wards.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. ZHANG YY , Xia HH, Zhuan ZH, Zhong J, et al
    Review article: "True" re-infection of Helicobacter pylori after successful eradication: worldwide annual rates, risk factors and clinical implications.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. CONCHILLO JM , Smout AJ
    Review article: Intraesophageal impedance monitoring for the assessment of bolus transit and gastroesophageal reflux.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
68. MASON JM , Raghunath AS, Hungin AP, Jackson W, et al
    Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. VAKIL N , Zullo A, Ricci C, Hassan C, et al
    Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
70. FUJINAMI H , Kudo T, Miyazaki T, Hosokawa A, et al
    Clinical trial: modified glucose clearance test: a novel non-invasive method for differentiating non-erosive reflux disease and erosive esophagitis.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. THIRUMURTHI S , Desilva R, Castillo DL, Richardson P, et al
    Identification of Helicobacter pylori infected patients using administrative data.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. CUTLER AG
    Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding: author's reply.
    Aliment Pharmacol Ther. 2008;28:500-1.
    PubMed     Text format     Related articles   
    
    
    
73. GISBERT JP , Calvet X, Feu F, Bory F, et al
    Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.
    Aliment Pharmacol Ther. 2008;28:499-500.
    PubMed     Text format     Related articles   
    
    
    
74. LANZA FL , Marathi UK, Anand BS, Lichtenberger LM, et al
    Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients.
    Aliment Pharmacol Ther. 2008;28:431-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. MULLIN JM , Valenzano MC, Whitby M, Lurie D, et al
    Esomeprazole induces upper gastrointestinal tract transmucosal permeability (R2).
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. OLSEN KM , Devlin JW
    Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients.
    Aliment Pharmacol Ther. 2008;28:326-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
77. RUZINEWSKI P , Soufflet C, Barthelemy P
    Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. VILLORIA A , Garcia P, Calvet X, Gisbert JP, et al
    Meta-analysis: High-dose proton pump inhibitors versus standard dose in triple therapy for Helicobacter pylori eradication.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. S TAHA A , Angerson WJ, Prasad R, McCloskey C, et al
    The incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and non-steroidal anti-inflammatory drugs.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. CHRISTIANSEN C , Christensen S, Riis A, Thomsen RW, et al
    Antipsychotic drugs and short-term mortality after peptic ulcer perforation: A population-based cohort study.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. ARMSTRONG D
    Systematic review: persistence and severity in gastroesophageal reflux disease.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. TARGOWNIK LE , Metge CJ, Leung S
    Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications.
    Aliment Pharmacol Ther. 2008;28:88-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
83. MASSO GONZALEZ EL , Garcia Roderiguez LA
    Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
84. CALABRESE C , Liguori G, Gabusi V, Gionchetti P, et al
    96-hour wireless esophageal pH-monitoring following proton pump inhibitor administration in NERD patients.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. OLSEN KM , Devlin JW
    Comparison of enteral and intravenous lansoprazole pharmacodynamic response in critically ill patients.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
86. HUNT RH , Armstrong D, Yaghoobi M, James C, et al
    Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
87. DE JONGE PJ , Siersema PD, van Breda SG, van Zoest KP, et al
    Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adducts.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. SOEST EM , Dieleman JP, Sturkenboom MC, Siersema PD, et al
    Gastro-oesophageal reflux, medical resource utilisation and upper gastrointestinal endoscopy in patients at risk of oesophageal adenocarcinoma.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. PACE F , Pallotta S, Tonini M, Vakil N, et al
    Systematic review; gastroesophageal reflux disease and dental lesions.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. CHASSANY O , Holtmann G, Malagelada J, Gebauer U, et al
    Systematic Review: A Systematic Review of Health-Related Quality of Life (HRQOL) Questionnaires in Gastroesophageal Reflux Disease (GERD).
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. YEOMANS ND , Naesdal J
    Systematic review: ulcer definition in NSAID ulcer prevention trials.
    Aliment Pharmacol Ther. 2008;27:465-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
92. WAHLQVIST P , Karlsson M, Johnson D, Carlsson J, et al
    Relationship between symptom load of gastroesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. HIRSCHOWITZ BI , Worthington J, Mohnen J
    Vitamin b12 deficiency in hypersecretors during long-term acid suppression with proton-pump inhibitors.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. RUBIN G , Uebel P, Brimo-Hayek A, Hey KH, et al
    Validation of a brief symptom questionnaire (ReQuest in Practice(trade mark)) for patients with gastroesophageal reflux disease (GERD).
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. GLUUD LL , Klingenberg SL, Langholz SE
    Tranexamic acid for upper gastrointestinal bleeding: systematic review of randomised trials.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
96. SUNG JJ , Mossner J, Barkun A, Kuipers EJ, et al
    Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of the Peptic Ulcer Bleed study.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. GALMICHE JP , Zerbib F, Bruley des Varannes S
    Review article: respiratory manifestations of gastro-oesophageal reflux disease (GORD).
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. NOJKOV B , Rubenstein J, Adlis S, Shaw M, et al
    Predictors of response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: the impact of co-morbidities on treatment outcomes and quality of life.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. DEN ELZEN WP , Groeneveld Y, De Ruijter W, Souverijn JH, et al
    Long-term use of proton pump inhibitors (PPIs) and vitamin B12 status in elderly individuals.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2007
100. DE VRIES AC , Kuipers EJ
     Review article: Helicobacter pylori eradication for the prevention of gastric cancer.
     Aliment Pharmacol Ther. 2007;26 Suppl 2:25-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. OUDKERK POOL M
     Review article: Gastro-oesophageal reflux disease--application of the concept of complete remission.
     Aliment Pharmacol Ther. 2007;26 Suppl 2:13-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. SMOUT AJ
     Review article: The measurement of non-acid gastro-oesophageal reflux.
     Aliment Pharmacol Ther. 2007;26 Suppl 2:7-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. SCHWARTZ MP , Smout AJ
     Review article: The endoscopic treatment of gastro-oesophageal reflux disease.
     Aliment Pharmacol Ther. 2007;26 Suppl 2:1-6.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: